Related Experiment Videos
Immunophenotypic studies in cutaneous T-cell lymphomas: clinical implications
E Ralfkiaer1, A Wollf-Sneedorff, K Thomsen
1Department of Pathology, Rigshospitalet, University of Copenhagen, Denmark.
The British Journal of Dermatology
|December 1, 1993
Summary
Aberrant T-cell phenotypes in cutaneous T-cell lymphoma (CTCL) do not independently predict prognosis. Clinical stage and histology are more significant indicators for patient outcomes in CTCL.
Area of Science:
- Dermatology
- Oncology
- Immunology
Background:
- Cutaneous T-cell lymphoma (CTCL) is a group of malignant lymphomas affecting the skin.
- Neoplastic T-cells in CTCL can exhibit aberrant or suppressor phenotypes.
- The clinical significance of these T-cell phenotypes in CTCL requires further investigation.
Purpose of the Study:
- To determine if aberrant or suppressor T-cell phenotypes have independent prognostic implications in CTCL.
- To correlate T-cell phenotypes with clinical presentation and disease course in CTCL patients.
Main Methods:
- Biopsy examination of 62 patients with suspected or confirmed CTCL.
- Review of clinical records to assess disease progression and outcomes.
- Analysis of T-cell phenotypes in relation to specific CTCL subtypes (mycosis fungoides, Sézary syndrome, large-cell lymphoma).
Main Results:
- Twenty-four cases showed neoplastic cells with aberrant or suppressor T-cell phenotypes.
- Aggressive disease courses were observed in large-cell lymphomas and Sézary syndrome.
- Mycosis fungoides with plaque lesions exhibited an indolent course, while tumor lesions were more aggressive.
Conclusions:
- Aberrant or suppressor T-cell phenotypes in CTCL are not independently prognostic.
- Clinical stage and histological examination are more critical factors for predicting CTCL patient outcomes.
- Prospective analysis is recommended to further validate these findings.